Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
2022 · New England Journal of Medicine · 2,396 citations
https://doi.org/10.1056/nejmoa2203690
K
Keun Seok Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
340
Papers
14.4K
Citations
49
h-index
135
i10-index
Keun Seok Lee is an academic researcher from Ewha Womans University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 49, co-authored 289 publications.
ORCID: 0000-0001-5575-836XPapers by this author
worksBuparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial
2017 · The Lancet Oncology · 379 citations
https://doi.org/10.1016/s1470-2045(17)30688-5
Breast cancer subtypes and survival in patients with brain metastases
2008 · Breast Cancer Research · 227 citations
https://doi.org/10.1186/bcr1870
Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer
2010 · Breast Cancer Research and Treatment · 216 citations
https://doi.org/10.1007/s10549-010-0780-8
Metaplastic breast cancer: clinicopathological features and its prognosis
2012 · Journal of Clinical Pathology · 127 citations
https://doi.org/10.1136/jclinpath-2011-200586
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
2016 · Cancer Research and Treatment · 118 citations
https://doi.org/10.4143/crt.2016.289
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat